Literature DB >> 21900878

Medullary amyloidosis associated with apolipoprotein A-IV deposition.

Sanjeev Sethi1, Jason D Theis, Shirley M Shiller, Cynthia C Nast, David Harrison, Helmut G Rennke, Julie A Vrana, Ahmet Dogan.   

Abstract

Amyloidosis is caused by extracellular deposition of proteins in an insoluble manner within tissues. In hereditary forms of amyloidosis, transthyretin, fibrinogen A-α, lysozyme, gelsolin, apolipoprotein A-I, and A-II accumulate in the tissue plaques. Here we describe a 52-year-old man with no family history of renal disease who presented with increased urinary frequency, gradual loss of renal function but no significant proteinuria. Renal biopsy found large amounts of amyloid restricted to the medulla with no involvement of glomeruli or vessels. Immunohistochemical analysis for transthyretin or serum amyloid A and tests for an underlying monoclonal gammopathy were negative. Although initially suspected to be amyloid light chain amyloidosis, laser microdissection and mass spectrometry showed that the amyloid was composed of large amounts of apolipoprotein A-IV. This was based on mass spectrometry studies that showed 100, 96, and 73 spectra in three microdissected samples that matched to apolipoprotein A-IV with 100% probability. DNA analyses detected three sequence variants representing common polymorphisms of the apolipoprotein A-IV gene. Thus, in this case, apolipoprotein A-IV deposition and renal involvement appear to be restricted to the medulla. A high degree of suspicion is required for the diagnosis of apolipoprotein A-IV amyloidosis as it may be missed if a renal biopsy consists only of cortex.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21900878     DOI: 10.1038/ki.2011.316

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  19 in total

Review 1.  Pathology and diagnosis of renal non-AL amyloidosis.

Authors:  Sanjeev Sethi; Jason D Theis
Journal:  J Nephrol       Date:  2017-08-21       Impact factor: 3.902

2.  Disrupting the DREAM transcriptional repressor complex induces apolipoprotein overexpression and systemic amyloidosis in mice.

Authors:  Pirunthan Perampalam; Haider M Hassan; Grace E Lilly; Daniel T Passos; Joseph Torchia; Patti K Kiser; Andrea Bozovic; Vathany Kulasingam; Frederick A Dick
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

3.  A systemic apolipoprotein A-IV-associated amyloidosis confirmed by proteome analysis.

Authors:  Taro Murakami; Akira Takasawa; Asako Moriki; Yusuke Igaki; Hiroshi Ikeda; Kazuyuki Murase; Kohichi Takada; Kazufumi Magara; Tomoyuki Aoyama; Yusuke Ono; Daisuke Kyuno; Kumi Takasawa; Masaki Murata; Makoto Osanai
Journal:  Virchows Arch       Date:  2021-03-10       Impact factor: 4.064

4.  Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases.

Authors:  Samar M Said; Sanjeev Sethi; Anthony M Valeri; Nelson Leung; Lynn D Cornell; Mary E Fidler; Loren Herrera Hernandez; Julie A Vrana; Jason D Theis; Patrick S Quint; Ahmet Dogan; Samih H Nasr
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-23       Impact factor: 8.237

5.  Novel Type of Renal Amyloidosis Derived from Apolipoprotein-CII.

Authors:  Samih H Nasr; Surendra Dasari; Linda Hasadsri; Jason D Theis; Julie A Vrana; Morie A Gertz; Prasuna Muppa; Michael T Zimmermann; Karen L Grogg; Angela Dispenzieri; Sanjeev Sethi; W Edward Highsmith; Giampaolo Merlini; Nelson Leung; Paul J Kurtin
Journal:  J Am Soc Nephrol       Date:  2016-06-13       Impact factor: 10.121

6.  IgD heavy-chain deposition disease: detection by laser microdissection and mass spectrometry.

Authors:  Virginie Royal; Patrick Quint; Martine Leblanc; Richard LeBlanc; Garrett F Duncanson; Robert L Perrizo; Fernando C Fervenza; Paul Kurtin; Sanjeev Sethi
Journal:  J Am Soc Nephrol       Date:  2014-09-05       Impact factor: 10.121

Review 7.  Pathophysiology and treatment of systemic amyloidosis.

Authors:  Julian D Gillmore; Philip N Hawkins
Journal:  Nat Rev Nephrol       Date:  2013-08-27       Impact factor: 28.314

8.  Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis.

Authors:  Sanjeev Sethi; Julie A Vrana; Jason D Theis; Nelson Leung; Anjali Sethi; Samih H Nasr; Fernando C Fervenza; Lynn D Cornell; Mary E Fidler; Ahmet Dogan
Journal:  Kidney Int       Date:  2012-04-11       Impact factor: 10.612

Review 9.  Amyloid nephropathy.

Authors:  Mazdak A Khalighi; W Dean Wallace; Miguel F Palma-Diaz
Journal:  Clin Kidney J       Date:  2014-03-13

10.  D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile.

Authors:  Sophie Valleix; Guglielmo Verona; Noémie Jourde-Chiche; Brigitte Nédelec; P Patrizia Mangione; Frank Bridoux; Alain Mangé; Ahmet Dogan; Jean-Michel Goujon; Marie Lhomme; Carolane Dauteuille; Michèle Chabert; Riccardo Porcari; Christopher A Waudby; Annalisa Relini; Philippa J Talmud; Oleg Kovrov; Gunilla Olivecrona; Monica Stoppini; John Christodoulou; Philip N Hawkins; Gilles Grateau; Marc Delpech; Anatol Kontush; Julian D Gillmore; Athina D Kalopissis; Vittorio Bellotti
Journal:  Nat Commun       Date:  2016-01-21       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.